Factor IX gene therapy (Transkaryotic therapies)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameFactor IX gene therapy (Transkaryotic therapies)
Drug Alias Namecarboxylase gene (Transkaryotic therapies)
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy
Mechanisms of ActionCoagulation factor IX stimulants
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShire Human Genetic Therapies, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Human Genetic Therapies, Inc
Active IndicationsN/A
Inactive IndicationsHemophilia B

Other Information

ATC CodeN/A
Related LinksN/A